Skip to main content
Erschienen in: BMC Gastroenterology 1/2023

Open Access 01.12.2023 | Research

Innovative angiography: a new approach to discover more hepatic vein collaterals in patients with cirrhotic portal hypertension

verfasst von: Bowen Liu, Zhendong Yue, Ting Cui, Hongwei Zhao, Lei Wang, Zhenhua Fan, Yifan Wu, Mingming Meng, Ke Zhang, Li Jiang, Huiguo Ding, Yuening Zhang, Fuquan Liu

Erschienen in: BMC Gastroenterology | Ausgabe 1/2023

Abstract

Background

The hemodynamics of patients with cirrhosis and portal hypertension are complex and variable. We aimed to investigate differences in venous pressures determined by innovative angiography and conventional angiography using balloon occlusion of the hepatic veins in patients with alcoholic cirrhosis and portal hypertension.

Methods

A total of 134 patients with alcoholic cirrhosis who fulfilled the inclusion criteria from June 2017 to June 2020 were included. During transjugular intrahepatic portosystemic shunt, conventional and innovative angiography were performed, and venous pressures were measured. A paired t-test and Pearson’s correlation coefficient were used for analysis.

Results

Conventional and innovative hepatic angiography detected lateral branches of the hepatic vein in 26 (19.4%) and 65 (48.5%) cases, respectively (P < 0.001). Innovative angiography detected a total of 65 patients with lateral shunts, of whom 37 (56.9%) had initial shunts. The average wedged hepatic venous pressure and portal venous pressure of the initial lateral branches were 21.27 ± 6.66 and 35.84 ± 7.86 mmHg, respectively, with correlation and determination coefficients of 0.342 (P < 0.05) and 0.117, respectively. The mean hepatic venous pressure gradient and portal pressure gradient were 9.59 ± 7.64 and 26.86 ± 6.78 mmHg, respectively, with correlation and determination coefficients of 0.292 (P = 0.079) and 0.085, respectively.

Conclusions

Innovative angiography reveals collateral branches of the hepatic veins more effectively than conventional angiography. Hepatic vein collateral branches are the primary factors leading to underestimation of wedged hepatic venous pressures and hepatic venous pressure gradients, with the initial hepatic vein collateral branches resulting in the most severe underestimations.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
HVPG
Hepatic venous pressure gradient
PPG
Portal pressure gradient
WHVP
Wedged hepatic venous pressure
PVP
Portal venous pressure
TIPS
Transjugular intrahepatic portosystemic shunt
FHVP
Free hepatic venous pressure
IVCP
Inferior vena cava pressure

Background

Hepatitis and alcoholism are common causes of cirrhotic portal hypertension [1, 2]. Hepatocytes are damaged by prolonged heavy drinking, and a series of pathological changes in the liver may occur, resulting in increased portal vein pressure and, eventually, leading to a series of clinical symptoms, such as esophageal gastric varices, gastrointestinal bleeding, and ascites [3, 4]. These symptoms are directly related to a gradual increase in portal vein pressure. The most accurate diagnosis and prognosis prediction for patients should be the direct measurement of portal vein pressure. However, precise measurement of portal vein pressure is complicated, traumatic, and technically demanding; therefore, it is difficult to routinely apply in clinical practice.
In recent years, the measurement of hepatic vein pressure in lieu of portal vein pressure has been used clinically and in research. The hepatic venous pressure gradient (HVPG) can be used as the "gold standard" to indirectly reflect the portal pressure gradient (PPG) [47]. Nevertheless, few studies have been conducted on the correlation between the HVPG and PPG in clinical practice. It has been suggested that there is a certain correlation between wedged hepatic venous pressure (WHVP) and portal venous pressure (PVP) in patients with portal hypertension and alcoholic cirrhosis [8], but these cases are limited. There is a standard for measuring hepatic venous pressure; injection of contrast agent (5 mL) after balloon occlusion of the hepatic vein is an important component of the standardized procedure for observing hepatic vein collateral branches and hepatic vein occlusion. It has been reported that the presence of collateral branches of the hepatic vein affects the accuracy of WHVP, but the detection rate is relatively low [9].
In this study, 134 patients with alcoholic cirrhosis and portal hypertension who fulfilled the inclusion criteria from June 2017 to June 2020 were enrolled for transjugular intrahepatic portosystemic shunt (TIPS) and underwent innovative hepatic venous angiography based on conventional measurement of hepatic venous pressure and angiography. Subsequently, we analyzed the correlation between the hepatic vein anatomy and venous pressure.

Methods

Patients

A total of 134 (males: 119 [88.8%], females: 15 [11.2%]; mean age: 55.02 ± 10.65 [range: 19–75] years) patients with alcoholic cirrhosis who fulfilled the inclusion criteria for portal hypertension underwent TIPS between January 2017 and June 2020. PPG and HVPG were obtained by measuring various pressures during the interventional surgery. There were 88 cases of gastrointestinal hemorrhage in patients with alcoholic cirrhosis and portal hypertension (65.7%), 35 cases of intractable ascites or pleural effusion combined with ascites (26.1%), and 11 cases of gastrointestinal bleeding with intractable ascites (8.2%). According to Child–Pugh classification, there were 36 grade A, 47 grade B, and 51 grade C cases. Fourteen cases of alcoholic cirrhosis with portal hypertension were complicated with liver cancer. The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki (6th revision, 2008) and was approved by the Ethics Committee of Beijing Shijitan Hospital (2018(01)). Informed consent was obtained from each patient included in the study.

Inclusion criteria

The inclusion criteria were as follows: 1) TIPS indications, 2) age 18–75 years, 3) presence of TIPS and undergoing elective surgery, and 4) normal hepatic vein and inferior vena cava.

Exclusion criteria

The exclusion criteria were as follows: 1) portal vein carcinoma thrombus, 2) arterioportal venous fistula, 3) portal vein thrombosis affecting blood flow (generally exceeding 1/3 of the portal vein), 4) use of drugs affecting portal vein pressure within the preceding week, and 5) presence of factors that affect the accuracy of intraoperative pressure measurement, such as biliary-cardiac reflex and incomplete balloon occlusion.

Method of pressure measurement

Preoperative preparation

Various examinations were conducted before the surgery, including routine blood examination, hepatorenal function, ICG-R15 (quantitative determination of liver function, retention rate of indocyanine green in 15 min), blood ammonia, blood type, electrocardiograph, coagulation function, portal vein ultrasound, and abdominal CT and/or magnetic resonance imaging. Coagulation function, platelet count, bilirubin, albumin, and hemoglobin levels should be adjusted according to the interventional surgery. The effects and risks of the surgery were explained to patients and their families, and consent for surgery was obtained. Medications affecting portal vein pressure were discontinued for at least one week preceding surgery.

Pressure measurement

Conventional methods of measuring pressure [10, 11]
Pressure was measured by catheterization of the right internal jugular vein to the right atrium, inferior vena cava, and hepatic vein under routine disinfection and local anesthesia. A Fogarty balloon catheter (Edward Company, USA) was inserted into the hepatic vein using an RUPS-100 outer sheath (COOK Company, USA). The tip of the balloon catheter was placed 3–5 cm from the hepatic vein to the opening of the inferior vena cava. WHVP and FHVP were measured before and after hepatic vein occlusion by expanding the balloon (contrast agent (5 mL) was carefully injected). The pressure was recorded after stabilization; the pressure measurement was repeated three times, and the average value was recorded; the HVPG value was then calculated. The liver parenchyma and portal vein were punctured through the hepatic vein or inferior vena cava. After successful portal vein puncture, a porcine tail catheter was inserted into the splenic or superior mesenteric vein for angiography. Before the shunt, the main portal vein pressure was measured three times; the average value was recorded and the PPG value was then calculated.
Innovative method of angiography
After completion of the standard measurement methods, the hepatic vein was blocked again by inserting a balloon at the same position as was done in the conventional method. The dose of contrast agent was increased (5 mL/s up to a total of 15 mL), and pressure angiography was performed; the pressure was 200–300 psi, and continuous angiography was performed for more than 6 s. Subsequently, subtraction was performed. The WHVP and free hepatic venous pressure (FHVP) were measured again; the pressure was recorded after stabilization, and the measurement was repeated three times; the average value was used to calculate the HVPG value.
Precautions
To observe the occlusion of the balloon catheter after balloon dilatation, if the blockage was incomplete, the position was adjusted and retested; radiography of the balloon catheter was performed. The indwelling catheter in the portal vein was inserted for 24–48 h; the portal vein pressure was measured at least three times per day. The pressures of the inferior vena cava and right atrium were measured three times during extubation, and the average value was recorded.

Statistical analysis

GraphPad Prism 8 (GraphPad, Inc., La Jolla, CA, USA) was used for the statistical analysis. The paired t-test was used to analyze the differences between WHVP and PVP, PPG and HVPG, and FHVP and IVCP. The Pearson correlation test was applied to analyze the correlation and determination coefficients. Blood pressures are expressed as means ± standard deviations. P < 0.05 was considered statistically significant.

Results

Differences between conventional and innovative angiography

Conventional and innovative hepatic angiography detected hepatic vein collateral branches in 26 (19.4%) and 65 (48.5%) cases, respectively. The difference was statistically significant (P < 0.001) (Fig. 1).

Individual pressure correlations in patients with collateral vessels detected by conventional angiography

Twenty-six patients with collateral branches underwent conventional angiography (Fig. 2A). The average WHVP and PVP were 20.89 ± 6.69 and 34.96 ± 8.08 mmHg (Table 1); the correlation and determination coefficients were 0.303 (P = 0.133) and 0.092, respectively (Fig. 3A). The average HVPG and PPG were 9.86 ± 7.44 and (25.94 ± 7.42) mmHg, respectively (Table 2). The coefficients of correlation and determination were 0.208 (P = 0.309) and 0.043, respectively (Fig. 4A).
Table 1
Correlation between WHVP and PVP in lateral branch imaging of different hepatic veins
 
WHVP (mmHg)
PVP (mmHg)
r
R2
P-value
Conventional angiography
20.89 ± 6.69
34.96 ± 8.08
0.303
0.092
0.133
Early shunting
21.27 ± 6.66
35.84 ± 7.86
0.342
0.117
0.038
Middle shunting
28.79 ± 6.94
35.64 ± 4.51
0.208
0.043
0.353
Late shunting
30.50 ± 8.31
34.83 ± 8.11
0.995
0.991
 < 0.001
Portal vein development
31.07 ± 7.53
32.39 ± 6.58
0.800
0.640
 < 0.001
No shunting
35.49 ± 7.78
30.13 ± 6.01
0.570
0.325
0.004
Table 2
Correlation between HVPG and PPG in lateral branch imaging of different hepatic veins
 
HVPG (mmHg)
PPG (mmHg)
r
R2
P-value
Conventional angiography
9.86 ± 7.44
25.94 ± 7.42
0.208
0.043
0.309
Early shunting
9.59 ± 7.64
26.86 ± 6.78
0.292
0.085
0.079
Middle shunting
15.62 ± 5.39
26.23 ± 5.70
0.264
0.069
0.236
Late shunting
17.00 ± 10.02
27.33 ± 7.97
0.779
0.607
0.068
Portal vein development
20.18 ± 8.31
23.99 ± 6.75
0.638
0.407
 < 0.001
No shunting
23.50 ± 9.30
20.83 ± 6.78
0.334
0.111
0.111

Initial shunt: the most significant factor causing underestimation of WHVP and HVPG in innovative angiography

Among the 65 patients with lateral branches detected by innovative angiography, 37 cases (56.9%) (Fig. 5A) possessed initial shunts, 22 cases (33.8%) (Fig. 5B) had mid-term shunts, and 6 cases (9.2%) (Fig. 5C) exhibited late shunts (Fig. 6). For the initial shunt, average WHVP and PVP were 21.27 ± 6.66 and 35.84 ± 7.86 mmHg, respectively, with determination coefficients of 0.342 (P = 0.038) and 0.117, respectively (Table 1). The HVPG and PPG were 9.59 ± 7.64 and 26.86 ± 6.78 mmHg, respectively, with correlation and determination coefficients of 0.292 (P = 0.079) and 0.085, respectively (Table 2). For the middle shunts, the mean WHVP and PVP were 28.79 ± 6.94 and 35.64 ± 4.51 mmHg, respectively, with correlation and determination coefficients of 0.208 (P = 0.353) and 0.043, respectively (Table 1). The average HVPG and PPG were 15.62 ± 5.39 and 26.23 ± 5.70 mmHg, respectively, with correlation and determination coefficients of 0.264 (P = 0.236) and 0.069, respectively (Table 2). The mean WHVP and PVP of hepatic collaterals in cases with late shunts were 30.50 ± 8.31 and 34.83 ± 8.11 mmHg, respectively, with correlation and determination coefficients of 0.995 (P < 0.001) and 0.991, respectively (Table 1). The average HVPG and PPG were 17.00 ± 10.02 and 27.33 ± 7.97 mmHg, respectively with correlation and determination coefficients of 0.779 (P = 0.068) and 0.607, respectively (Table 2).

Venous pressure without collaterals on conventional angiography

There were 108 patients (81.6%) without collateral branches on conventional hepatic venography (Fig. 2B). The average WHVP and PVP were 30.65 ± 8.17 and 33.25 ± 6.60 mmHg, respectively, with correlation and determination coefficients of 0.368 (P < 0.001) and 0.135, respectively. The mean HVPG and PPG were 18.67 ± 9.05 and 24.44 ± 6.79 mmHg, respectively, with correlation and determination coefficients of 0.263 (P = 0.006) and 0.069, respectively.

Innovative angiography for various venous pressure situations without collateral vessels

Sixty-nine patients (51.5%) underwent innovative hepatic venography without detection of collaterals, including 45 patients (65.2%) (Fig. 7A) with portal vein visualization (Fig. 5D) and 24 patients (34.8%) (Fig. 7B) without visualization (Fig. 5E). The mean WHVP and PVP of the 45 patients with portal vein imaging were 31.07 ± 7.53 and 32.39 ± 6.58 mmHg (Table 1), respectively, with correlation and determination coefficients of 0.800 (P < 0.001) and 0.640, respectively (Fig. 3B). The average HVPG and PPG were 20.18 ± 8.31 and 23.99 ± 6.75 mmHg (Table 2), with correlation and determination coefficients of 0.638 (P < 0.001) and 0.407, respectively (Fig. 4B). The mean WHVP and PVP of the 24 patients without portal vein visualization were 35.49 ± 7.78 mmHg and 30.13 ± 6.01 mmHg (Table 1), respectively, with correlation and determination coefficients of 0.570 (P = 0.004) and 0.325, respectively (Fig. 3C). The average HVPG and PPG were 23.50 ± 9.30 and 20.83 ± 6.78 mmHg (Table 2), respectively, with correlation and determination coefficients of 0.334 (P = 0.111) and 0.111, respectively (Fig. 4C).

Discussion

Alcoholic cirrhosis is a common cause of portal hypertension. Hemodynamic changes in portal hypertension caused by pathological changes in alcoholic cirrhosis occur mainly in the hepatic sinus, resulting in portal vein resistance and increased blood volume [12, 13]. Normal liver hemodynamics are that the PVP is higher than or equal to the hepatic sinusoidal pressure, WHVP is equal to the hepatic sinusoidal pressure, and the FHVP is higher than the IVCP by 0.5–1.0 mmHg [1416]. PPG is more meaningful and accurate than PVP in predicting the risk of complications associated with portal hypertension [17]. Theoretically, the HVPG can accurately reflect the PPG. It is preferred to represent PPG because it is simple, is associated with minimal trauma, and is easily accepted by patients [4, 18, 19]. There are significant changes in the structure of the liver tissue, hepatic lobules, and microvessels in patients with alcoholic cirrhosis and portal hypertension [2, 20, 21]. In pathological conditions and clinical practice, whether WHVP accurately represents PVP remains controversial in reports [22].
However, it has rarely been reported whether the HVPG represents PPG. The basic principle of measuring WHVP is that after the hepatic vein is completely blocked by a balloon, hepatic vein pressure gradually increases until it achieves the pressure of the hepatic sinuses; this accurately represents the pressure of the hepatic sinuses [22, 23]. However, in the process of measurement, certain objective and subjective factors can impede accurate measurement. For example, in the presence of collateral branches of the hepatic vein, the blood does not achieve the pressure of the hepatic sinusoid, but blood flows from the collateral branches to other hepatic veins or accessory hepatic veins into the inferior vena cava, or may even flow away quickly in the preliminary stage [16, 24]. In addition, among the subjective factors, if balloon sealing is insufficient to enable the pressure of the hepatic sinusoid to be reached and the front end of the balloon catheter is not free in the blood vessel, the accuracy of the measured pressure is directly affected. Based on the principle of measuring WHVP, as long as lateral branches of the hepatic vein exist, it is possible that the WHVP will not truly represent the pressure of the hepatic sinus.
By using innovative hepatic venography in this study, we detected more collateral branches of the hepatic vein (48.5%) than those identified using the conventional method (19.4%). Furthermore, in patients with collateral branches of the hepatic vein, the WHVP was significantly lower than the PVP and HVPG was significantly lower than PPG. Hepatic vein collateral flow is the key factor causing underestimation of WHVP and HVPG. Moreover, our analysis revealed that hepatic vein collateral branches appeared at the three shunt levels, and this underestimation was more obvious the earlier the shunt appeared. In addition to identifying more cases with hepatic vein collaterals, 45 patients (33.6% of total cases) underwent portal vein imaging in the innovative hepatic venography group in this study. The correlation between WHVP and PVP in these patients was good, and the same was true for the HVPG and PPG. This was because the pressure of the hepatic vein increased after it was filled with the contrast agent. When the pressure of the hepatic vein was balanced with that of the hepatic sinus, the contrast agent entered the portal vein through the hepatic sinus countercurrent, which enabled portal vein imaging, indicating that the hepatic sinus pressure was roughly equal to the portal vein pressure. Furthermore, 24 patients (17.9% of the total cases) had no hepatic vein collateral branches. The mean WHVP of these patients (35.49 ± 7.78 mmHg) was higher than the mean PVP (30.13 ± 6.01 mmHg), with correlation and determination coefficients of 0.570 (P = 0.004) and 0.325, respectively. The mean HVPG (23.50 ± 9.30 mmHg) was higher than the PPG (20.83 ± 6.78 mmHg); the correlation and determination coefficients were 0.334 (P = 0.111), and 0.111, respectively. Since the hepatic vein was perfused with contrast medium, the hepatic venous pressure gradually increased, and the contrast medium could not enter the portal vein through the hepatic sinusoids (possibly the blood of the hepatic sinusoids is mainly supplied by the hepatic artery) because of the higher hepatic sinusoidal pressure. The contrast medium was retained in the hepatic vein and could not enter the portal vein or the hepatic venous collateral return. Therefore, the absence of collateral branches of the hepatic vein is an important reason for the overestimation of WHVP and HVPG. Studies [9, 25, 26] have reported that patients with WHVP higher than PVP have adverse hepatic blood flow, umbilical vein opening, portocaval anastomotic branches, and gastro-renal shunts. Among the patients in this study, only two had this condition.
Regarding the measurement of free pressure in the inferior vena cava, hepatic vein, and portal vein, the factors affecting the accuracy of measurement are mainly subjective [19, 25, 27]. For example, preoperative health education should be incorporated so that patients can be fully prepared psychologically. Patients who choose an elective operation should be prepared, and patients with massive ascites should ensure drainage of the ascites appropriately and discontinue drugs that affect venous pressure (non-selective beta-blockers influence PVP [2830], deep sedation using propofol impacts the PPG in patients [31, 32]). During the surgery, the accuracy of the pressure measurement was also affected by the use of local anesthesia and the consistent position of the catheter for multiple pressure measurements. Therefore, it is imperative to pay special attention to patients with the biliary-cardiac reflex and incomplete balloon occlusions. These patients should be excluded if these conditions cannot be corrected.

Conclusions

In conclusion, innovative hepatic vein angiography can identify more cases of hepatic vein collateral branches in alcoholic cirrhosis with portal hypertension than conventional angiography. Hepatic vein collateral branches are the key factors leading to underestimation of WHVP and HVPG, of which the initial hepatic vein collateral branches exhibit the most profound impact, followed by the middle and late hepatic vein collateral branches. Additionally, this innovative method demonstrated good correlation of WHVP with PVP and HVPG with PPG in patients with portal vein visualization. The absence of hepatic vein collaterals is an important factor resulting in the overestimation of the WHVP and HVPG. However, whether additional factors exist requires further investigation. The total amount of contrast agent needed, injection dose (per second), and injection pressure that are most appropriate for innovative angiography also deserve further investigation.

Acknowledgements

The authors would like to express their gratitude to all the medical staff of the Interventional Therapy Department of Beijing Shijitan Hospital affiliated to Capital Medical University for assisting in the collection of clinical data.

Declarations

The research protocol followed every provision of the Declaration of Helsinki and was approved by the Ethics Committee of Beijing Shijitan Hospital (2018(01)). Written informed consent was obtained from all individual participants included in the study.
Not applicable.

Competing interests

The authors declare no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Garcia-Tsao G, Lim JK. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol. 2009;104:1802–29.CrossRefPubMed Garcia-Tsao G, Lim JK. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol. 2009;104:1802–29.CrossRefPubMed
4.
Zurück zum Zitat Bosch J, Abraldes JG, Berzigotti A, García-Pagan JC. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol. 2009;6:573–82.CrossRefPubMed Bosch J, Abraldes JG, Berzigotti A, García-Pagan JC. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol. 2009;6:573–82.CrossRefPubMed
5.
Zurück zum Zitat de Franchis R. Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743–52.CrossRefPubMed de Franchis R. Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743–52.CrossRefPubMed
6.
Zurück zum Zitat Simonetto DA, Liu M, Kamath PS. portal hypertension and related complications: diagnosis and management. Mayo Clin Proc. 2019;94:714–26.CrossRefPubMed Simonetto DA, Liu M, Kamath PS. portal hypertension and related complications: diagnosis and management. Mayo Clin Proc. 2019;94:714–26.CrossRefPubMed
7.
Zurück zum Zitat Wang T, Liang F, Zhou Z, Qi X. Global sensitivity analysis of hepatic venous pressure gradient (HVPG) measurement with a stochastic computational model of the hepatic circulation. Comput Biol Med. 2018;97:124–36.CrossRefPubMed Wang T, Liang F, Zhou Z, Qi X. Global sensitivity analysis of hepatic venous pressure gradient (HVPG) measurement with a stochastic computational model of the hepatic circulation. Comput Biol Med. 2018;97:124–36.CrossRefPubMed
8.
Zurück zum Zitat Deplano A, Migaleddu V, Pischedda A, et al. Portohepatic gradient and portal hemodynamics in patients with cirrhosis due to hepatitis C virus infection. Dig Dis Sci. 1999;44:155–62.CrossRefPubMed Deplano A, Migaleddu V, Pischedda A, et al. Portohepatic gradient and portal hemodynamics in patients with cirrhosis due to hepatitis C virus infection. Dig Dis Sci. 1999;44:155–62.CrossRefPubMed
9.
Zurück zum Zitat Osada Y, Kanazawa H, Narahara Y, Mamiya Y, Nakatsuka K, Sakamoto C. Wedged hepatic venous pressure does not reflect portal pressure in patients with cirrhosis and hepatic veno-venous communications. Dig Dis Sci. 2008;53:7–13.CrossRefPubMed Osada Y, Kanazawa H, Narahara Y, Mamiya Y, Nakatsuka K, Sakamoto C. Wedged hepatic venous pressure does not reflect portal pressure in patients with cirrhosis and hepatic veno-venous communications. Dig Dis Sci. 2008;53:7–13.CrossRefPubMed
10.
Zurück zum Zitat Consensus on clinical application of hepatic venous pressure gradient in China (2018). Chin J Clin Hepatol. 2018;34(12):2526–2536. Consensus on clinical application of hepatic venous pressure gradient in China (2018). Chin J Clin Hepatol. 2018;34(12):2526–2536.
11.
Zurück zum Zitat Reiberger T, Schwabl P, Trauner M, Peck-Radosavljevic M, Mandorfer M. Measurement of the hepatic venous pressure gradient and transjugular liver biopsy. J Vis Exp. 2020;(160). Reiberger T, Schwabl P, Trauner M, Peck-Radosavljevic M, Mandorfer M. Measurement of the hepatic venous pressure gradient and transjugular liver biopsy. J Vis Exp. 2020;(160).
12.
Zurück zum Zitat Merkel C, Montagnese S. Hepatic venous pressure gradient measurement in clinical hepatology. Dig Liver Dis. 2011;43:762–7.CrossRefPubMed Merkel C, Montagnese S. Hepatic venous pressure gradient measurement in clinical hepatology. Dig Liver Dis. 2011;43:762–7.CrossRefPubMed
13.
Zurück zum Zitat Aithal GP, Palaniyappan N, China L, et al. Guidelines on the management of ascites in cirrhosis. Gut. 2021;70:9–29.CrossRefPubMed Aithal GP, Palaniyappan N, China L, et al. Guidelines on the management of ascites in cirrhosis. Gut. 2021;70:9–29.CrossRefPubMed
14.
Zurück zum Zitat Perelló A, Escorsell A, Bru C, et al. Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis. Hepatology. 1999;30:1393–7.CrossRefPubMed Perelló A, Escorsell A, Bru C, et al. Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis. Hepatology. 1999;30:1393–7.CrossRefPubMed
15.
Zurück zum Zitat Boyer TD. Wedged hepatic vein pressure (WHVP): ready for prime time. Hepatology. 2006;43:405–6.CrossRefPubMed Boyer TD. Wedged hepatic vein pressure (WHVP): ready for prime time. Hepatology. 2006;43:405–6.CrossRefPubMed
16.
Zurück zum Zitat Rössle M, Blanke P, Fritz B, Schultheiss M, Bettinger D. Free hepatic vein pressure is not useful to calculate the portal pressure gradient in cirrhosis: a morphologic and hemodynamic study. J Vasc Interv Radiol. 2016;27:1130–7.CrossRefPubMed Rössle M, Blanke P, Fritz B, Schultheiss M, Bettinger D. Free hepatic vein pressure is not useful to calculate the portal pressure gradient in cirrhosis: a morphologic and hemodynamic study. J Vasc Interv Radiol. 2016;27:1130–7.CrossRefPubMed
17.
Zurück zum Zitat Turco L, Garcia-Tsao G. Portal hypertension: pathogenesis and diagnosis. Clin Liver Dis. 2019;23:573–87.CrossRefPubMed Turco L, Garcia-Tsao G. Portal hypertension: pathogenesis and diagnosis. Clin Liver Dis. 2019;23:573–87.CrossRefPubMed
18.
Zurück zum Zitat Groszmann RJ, Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology. 2004;39:280–2.CrossRefPubMed Groszmann RJ, Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology. 2004;39:280–2.CrossRefPubMed
19.
Zurück zum Zitat Qi X, Berzigotti A, Cardenas A, Sarin SK. Emerging non-invasive approaches for diagnosis and monitoring of portal hypertension. Lancet Gastroenterol Hepatol. 2018;3:708–19.CrossRefPubMed Qi X, Berzigotti A, Cardenas A, Sarin SK. Emerging non-invasive approaches for diagnosis and monitoring of portal hypertension. Lancet Gastroenterol Hepatol. 2018;3:708–19.CrossRefPubMed
20.
Zurück zum Zitat Steib CJ, Schewe J, Gerbes AL. Infection as a trigger for portal hypertension. Dig Dis. 2015;33:570–6.CrossRefPubMed Steib CJ, Schewe J, Gerbes AL. Infection as a trigger for portal hypertension. Dig Dis. 2015;33:570–6.CrossRefPubMed
21.
Zurück zum Zitat Shah V, García-Cardeña G, Sessa WC, Groszmann RJ. The hepatic circulation in health and disease: report of a single-topic symposium. Hepatology. 1998;27:279–88.CrossRefPubMed Shah V, García-Cardeña G, Sessa WC, Groszmann RJ. The hepatic circulation in health and disease: report of a single-topic symposium. Hepatology. 1998;27:279–88.CrossRefPubMed
22.
Zurück zum Zitat Ferrusquía-Acosta J, Bassegoda O, Turco L, et al. Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis. J Hepatol. 2021;74:811–8.CrossRefPubMed Ferrusquía-Acosta J, Bassegoda O, Turco L, et al. Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis. J Hepatol. 2021;74:811–8.CrossRefPubMed
23.
Zurück zum Zitat Silva-Junior G, Baiges A, Turon F, et al. The prognostic value of hepatic venous pressure gradient in patients with cirrhosis is highly dependent on the accuracy of the technique. Hepatology. 2015;62:1584–92.CrossRefPubMed Silva-Junior G, Baiges A, Turon F, et al. The prognostic value of hepatic venous pressure gradient in patients with cirrhosis is highly dependent on the accuracy of the technique. Hepatology. 2015;62:1584–92.CrossRefPubMed
24.
Zurück zum Zitat Monroe EJ, Michalsky WS, Koo KSH, et al. Intrahepatic veno-venous collateralization and misrepresentative hepatic venous pressure gradients in children. Pediatr Radiol. 2020;50:1579–86.CrossRefPubMed Monroe EJ, Michalsky WS, Koo KSH, et al. Intrahepatic veno-venous collateralization and misrepresentative hepatic venous pressure gradients in children. Pediatr Radiol. 2020;50:1579–86.CrossRefPubMed
25.
Zurück zum Zitat Reverter E, Blasi A, Abraldes JG, et al. Impact of deep sedation on the accuracy of hepatic and portal venous pressure measurements in patients with cirrhosis. Liver Int. 2014;34:16–25.CrossRefPubMed Reverter E, Blasi A, Abraldes JG, et al. Impact of deep sedation on the accuracy of hepatic and portal venous pressure measurements in patients with cirrhosis. Liver Int. 2014;34:16–25.CrossRefPubMed
26.
Zurück zum Zitat Pomier-Layrargues G, Kusielewicz D, Willems B, et al. Presinusoidal portal hypertension in non-alcoholic cirrhosis. Hepatology. 1985;5:415–8.CrossRefPubMed Pomier-Layrargues G, Kusielewicz D, Willems B, et al. Presinusoidal portal hypertension in non-alcoholic cirrhosis. Hepatology. 1985;5:415–8.CrossRefPubMed
27.
28.
Zurück zum Zitat Alvarado-Tapias E, Ardevol A, Garcia-Guix M, et al. Short-term hemodynamic effects of β-blockers influence survival of patients with decompensated cirrhosis. J Hepatol. 2020;73:829–41.CrossRefPubMed Alvarado-Tapias E, Ardevol A, Garcia-Guix M, et al. Short-term hemodynamic effects of β-blockers influence survival of patients with decompensated cirrhosis. J Hepatol. 2020;73:829–41.CrossRefPubMed
29.
Zurück zum Zitat Groszmann RJ, Garcia-Tsao G, Bosch J, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med. 2005;353:2254–61.CrossRefPubMed Groszmann RJ, Garcia-Tsao G, Bosch J, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med. 2005;353:2254–61.CrossRefPubMed
30.
Zurück zum Zitat Villanueva C, Albillos A, Genescà J, et al. β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2019;393:1597–608.CrossRefPubMed Villanueva C, Albillos A, Genescà J, et al. β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2019;393:1597–608.CrossRefPubMed
31.
Zurück zum Zitat Lebrec D, Nouel O, Corbic M, Benhamou JP. Propranolol–a medical treatment for portal hypertension? Lancet. 1980;2:180–2.CrossRefPubMed Lebrec D, Nouel O, Corbic M, Benhamou JP. Propranolol–a medical treatment for portal hypertension? Lancet. 1980;2:180–2.CrossRefPubMed
32.
Zurück zum Zitat Mandell MS, Durham J, Kumpe D, Trotter JF, Everson GT, Niemann CU. The effects of desflurane and propofol on portosystemic pressure in patients with portal hypertension. Anesth Analg. 2003;97:1573–7.CrossRefPubMed Mandell MS, Durham J, Kumpe D, Trotter JF, Everson GT, Niemann CU. The effects of desflurane and propofol on portosystemic pressure in patients with portal hypertension. Anesth Analg. 2003;97:1573–7.CrossRefPubMed
Metadaten
Titel
Innovative angiography: a new approach to discover more hepatic vein collaterals in patients with cirrhotic portal hypertension
verfasst von
Bowen Liu
Zhendong Yue
Ting Cui
Hongwei Zhao
Lei Wang
Zhenhua Fan
Yifan Wu
Mingming Meng
Ke Zhang
Li Jiang
Huiguo Ding
Yuening Zhang
Fuquan Liu
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Gastroenterology / Ausgabe 1/2023
Elektronische ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-023-02792-6

Weitere Artikel der Ausgabe 1/2023

BMC Gastroenterology 1/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.